Comments on Proposed Rule Regarding Approach to PFAS Reporting Requirements and Supplier Notification for Chemicals of Special Concern Share page: Docket Number: EPA–HQ–TRI–2022–0270 Download Document Issues: OTC Medicines Dietary Supplements Consumer Medical Devices Other Issues Packaging Sustainability PFAS Related Posts Comments Comments Regarding FDA Annual Reportable Labeling Changes for New Drug Applications and Abbreviated New Drug Applications for Nonprescription Drug Products May 13, 2024 Press Releases and Statements CHPA Applauds Vermont for Passing Sun Safety Bill Empowering Students to Better Protect their Skin May 8, 2024 Press Releases and Statements Tennessee Expands Access to OTC Cold & Allergy Medications Containing PSE May 7, 2024